An AI-powered blood test that analyzes DNA fragments could detect silent liver disease long before symptoms begin.
Researchers from MIT and elsewhere have developed a more user-friendly and efficient method to help networking engineers ...
Abstract: Code-Switching (CS) Text-To-Speech (TTS) models have gained attention due to the increasing prevalence of multilingual communication. However, existing models struggle to meet the growing ...
Proceeds will fund the registrational STOP-Cdiff (SIDIPREV™ Trial On Prevention of C. difficile Infections) trial for SIDIPREV™, positioned to become the first prevention against C. difficile, a ...
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
Clostridium difficile infection (CDI) is not declining in the United States. Nucleic acid amplification tests (NAAT) are used as part of active surveillance testing programs to prevent health ...
GenePOC, a member of the Debiopharm Group(TM), is proud to announce the launch of its 2nd FDA cleared assay in less than 6 months, GenePOC(TM) CDiff, for use on the revogene(TM) instrument. The ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has provided 510(k) clearance for the cobas® Cdiff Test to detect Clostridium difficile (C. difficile) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results